Full-Time
Access Reimbursement Commercial Operations Lead
Posted on 9/4/2026
The Lockwood Group
201-500 employees
Healthcare consulting for post-Phase II publications
No salary listed
United States
Remote
Field-based role with travel for field rides, meetings, training sessions, and business reviews.
Bachelor's
 Sales & Account Management (1) |
|---|
Get referred to The Lockwood Group
See people who can refer or advise you
- A bachelor's degree or equivalent work experience.
- At least 5 years of experience in managed care, field reimbursement, patient services, specialty or biologics sales, or field operations.
- At least 3 years in access management roles, at least 3 years of direct people management experience, or relevant experience.
- Experience and understanding of retail and specialty pharmacies.
- Ability to conduct field rides, monitor compliance-related activities, attend team and client meetings, training sessions, and national or regional business reviews; travel requirements will be defined based on client expectations.
- Ensure all Access and Reimbursement Manager activities comply with approved program parameters, client policies, legal and compliance guidance, privacy requirements, adverse event and product complaint reporting obligations, and applicable federal and state requirements.
- Understanding of third-party data sets such as Symphony Health and copay data.
- Ability to deliver presentations using technology platforms such as Zoom, Webex, or Teams.
- Advanced knowledge of medical insurance terminology and payer policies.
- Knowledge of Centers for Medicare & Medicaid Services policies and processes, with expertise in Medicare Part D for pharmacy benefit products.
- Ability to track and monitor budgets, expenses, contracts, and operational deliverables for timely reporting and appropriate financial stewardship.
- Ability to manage ambiguity and solve problems.
- Ability to prepare and submit appropriate expense reports in a timely manner.
- A valid driver's license.
- Drive team development by managing a large team of more than 10 Access and Reimbursement Managers and fostering a high-performing culture with accountability for access-related objectives.
- Own day-to-day performance monitoring of Access and Reimbursement Manager key performance indicators, including activity, account engagement, access barrier trends, customer relationship management utilization, educational pull-through, and other agreed-upon measures.
- Translate performance trends into actionable coaching, operational adjustments, and executive-ready business reviews.
- Understand and articulate complex data sets and provide summaries, quarterly reports, and presentations for Executive Leadership.
- Liaise with the client's Data and Analytics team and Market Access Lead to improve and refine Access and Reimbursement Manager key performance indicators.
- Lead and manage operational activities including Access and Reimbursement Manager roster management, customer relationship management, dashboard reporting support, and other access performance measures.
- Coordinate initial Access and Reimbursement Manager onboarding, sourcing and recruiting support, expense tracking and reporting, training logistics, and meeting coordination with the client and team.
- Coach, mentor, and empower Access and Reimbursement Managers to deliver educational support to healthcare providers and patients to facilitate patient access.
- Provide strategic and operational oversight so Access and Reimbursement Managers deliver compliant education on payer coverage, prior authorization requirements, benefit verification workflows, appeals and denials processes, affordability resources, specialty pharmacy coordination, and patient support program navigation.
- Serve as a trusted advisor and partner to the client.
- Track and monitor budgets, expenses, contracts, and operational deliverables to ensure timely reporting and financial stewardship.
- Prepare and submit appropriate expense reports in a timely manner.
- Therapeutic expertise in cardiovascular is a plus.
The Lockwood Group is a healthcare and pharmaceutical consulting firm that helps late-stage drug developers (post-Phase 2) communicate data and prepare for market access. They provide strategic publication planning and the creation of scientifically accurate publications that meet regulatory standards, helping clients share new research with the public and stakeholders. They also offer prelaunch commercial support, identifying unmet market needs and guiding the product through launch and post-launch phases to maximize success. An affiliate, Random42, supplies medical animation to make complex scientific information visually engaging and easier to understand. The company operates on a service-based model, earning fees from project-based consulting engagements. Its goal is to support clients in delivering evidence-based, impactful communications and to enable successful market access and product launches in the competitive healthcare market.
Company Size
201-500
Company Stage
Acquired
Total Funding
N/A
Headquarters
Stamford, Connecticut
Founded
2007
Get referred to The Lockwood Group
See people who can refer or advise you
Simplify's Take
What believers are saying
- Lockwood acquired Total Health on February 23, 2026, expanding free oncology education.
- Nexus Health bought Stratis Group on March 17, 2026, strengthening market access capabilities.
- Lockwood's headcount reached 867 by March 2026, signaling continued growth.
What critics are saying
- RTP, Total Health, and Stratis integrations stretch management through 2026.
- Oncology spending concentration ties Lockwood to pharma launch timing and reimbursement volatility.
- Ares-backed roll-up failure destroys cross-sell credibility and buyer confidence fast.
What makes The Lockwood Group unique
- Lockwood combines medical communications, market access, and oncology education under one platform.
- Total Health and RTP deepen Lockwood's oncology credibility and clinician reach in 2025-2026.
- Random42 adds medical animation, separating Lockwood from text-only agency competitors.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Flexible Work Hours
Growth & Insights and Company News
6 month growth
↓ -1%1 year growth
↓ -1%2 year growth
↓ -1%Lockwood Group welcomes Total Health. The Lockwood Group has announced the acquisition of Total Health, the nation's leading provider of free, in-person oncology medical education for cancer care professionals. This strategic move enhances The Lockwood Group's educational offerings and deepens its commitment to delivering evidence-based clinical insights that improve patient care. Total Health has built a robust portfolio of high-impact, free, continuing medical education (CME) programs and conferences that equip multidisciplinary oncology teams with the latest research and clinical strategies. Delivering more than 60 programs annually across virtual and in-person formats, Total Health plays a unique role as a leading provider of oncology education, including collaborations with leading national oncology organizations and extensive reach across the cancer care community, aligning closely with The Lockwood Group's mission to translate complex scientific data into actionable clinical and commercial strategies. "We are thrilled to welcome Sarah Louden, her Total Health team, and community to The Lockwood Group," said Matthew Schecter, Founder & CEO of The Lockwood Group. "Total Health has a distinguished legacy of empowering oncology clinicians with trusted, accessible education. Their expertise in scaling impactful educational experiences complements our integrated service capabilities and will meaningfully expand the ways we serve clinicians across the oncology landscape." Founded by Sarah Louden, Total Health Oncology has established itself as a cornerstone organization in oncology education. Its portfolio of free programs, designed for physicians, nurses, pharmacists, and other cancer care providers, has set a standard for clinical excellence and lifelong learning in the oncology community. Total Health is widely recognized for convening high-caliber faculty and translating emerging data into practical, clinic-ready education for multidisciplinary teams. "Joining forces with The Lockwood Group opens an exciting new chapter for Total Health," said Sarah Louden, Founder & CEO of Total Health Oncology. "Together, we will amplify our reach, innovate how oncology education is delivered, and continue to support clinicians with the tools they need to deliver exceptional patient care. This next chapter strengthens our ability to serve the oncology community while preserving what has always defined us - free access, clinical relevance, and a deep commitment to education that improves outcomes." The acquisition further fortifies The Lockwood Group's leadership in oncology and medical education, adding to its strong portfolio of integrated communications, strategic consulting, and clinical insights services. With Total Health's deep expertise and broad educational footprint, The Lockwood Group will continue to expand access to high-quality, clinician-focused resources that advance clinical knowledge and support better decision-making across the cancer care continuum.
/PRNewswire/ -- The Lockwood Group, a global health care services and pharmaceutical communications organization, today announced the acquisition of Total...
The Lockwood Group announced the acquisition of Research To Practice (RTP), a leading provider of accredited oncology-focused medical education for healthcare professionals. This strategic move enhances The Lockwood Group’s position as a global healthcare services platform with expertise across medical communications, education, animation and visualization, regulatory and clinical consulting, and market access.
The Lockwood Group expands capabilities by welcoming Research To Practice. The Lockwood Group, a global health care services platform that offers a comprehensive suite of capabilities, bringing best-in-class expertise in medical communications, education, animation and visualization, regulatory and clinical consulting, and market access, is proud to announce the acquisition of Research To Practice (RTP), a recognized leader in accredited, oncology-focused medical education for health care professionals. This acquisition represents a pivotal step in The Lockwood Group's mission to elevate evidence-based information resources and empower clinicians with the knowledge needed to deliver the best possible care for patients. "We are thrilled to welcome Research To Practice to The Lockwood Group," said Matthew Schecter, Founder & CEO of The Lockwood Group. "RTP's deep expertise in oncology, their trusted relationships with clinical thought leaders, and their legacy of delivering best-in-class continuing education align seamlessly with The Lockwood Group's science-first, insight-driven approach. Together, we will expand our collective reach and continue delivering impactful education that improves patient care worldwide." Founded by medical oncologist Neil Love, MD, RTP has spent over 4 decades creating and delivering high-impact accredited educational activities that help cancer clinicians stay current in a rapidly evolving treatment landscape. RTP's unique content and innovative formats span live symposia, regional and local meetings, audio/video podcasts, multimedia webinars and roundtables, and other interactive formats, all grounded in real-world clinical challenges and enriched by expert perspectives. "Joining The Lockwood Group provides us the opportunity to further advance our mission of improving cancer care through education," said Dr Love. "Their strategic insight and global capabilities will help us further elevate and expand the ways we connect with and support the diverse needs of oncology clinicians." The partnership between The Lockwood Group and Research To Practice unites 2 organizations deeply committed to the people behind the science - clinicians, researchers, and patients. Together, they will continue to expand access to trusted, evidence-based education that drives better decisions and better care across the oncology community. About The Lockwood Group The Lockwood Group is a global pharma services organization with over 700 employees, that partners with pharmaceutical and biotechnology companies to translate complex science into compelling strategies that drive clinical and commercial success. Learn more at www.thelockwoodgrp.com. About Research To Practice RTP is a medical education company based in Miami, FL, specializing in physician and allied health professional education, focused exclusively on oncology and hematology. Founded and led by medical oncologist Neil Love, MD, RTP has provided meaningful, relevant, and unbiased educational perspectives for more than 40 years to meet the needs of oncology clinicians and positively impact the care of patients with cancer. Learn more at www.researchtopractice.com
The Lockwood Group expands capabilities by welcoming Research To Practice. News provided by. STAMFORD, Conn., Nov. 12, 2025 /PRNewswire/ - The Lockwood Group, a global health care services platform that offers a comprehensive suite of capabilities, bringing best-in-class expertise in medical communications, education, animation and visualization, regulatory and clinical consulting, and market access, is proud to announce the acquisition of Research To Practice (RTP), a recognized leader in accredited, oncology-focused medical education for health care professionals. This acquisition represents a pivotal step in The Lockwood Group's mission to elevate evidence-based information resources and empower clinicians with the knowledge needed to deliver the best possible care for patients. "We are thrilled to welcome Research To Practice to The Lockwood Group," said Matthew Schecter, Founder & CEO of The Lockwood Group. "RTP's deep expertise in oncology, their trusted relationships with clinical thought leaders, and their legacy of delivering best-in-class continuing education align seamlessly with The Lockwood Group's science-first, insight-driven approach. Together, we will expand our collective reach and continue delivering impactful education that improves patient care worldwide." Founded by medical oncologist Neil Love, MD, RTP has spent over 4 decades creating and delivering high-impact accredited educational activities that help cancer clinicians stay current in a rapidly evolving treatment landscape. RTP's unique content and innovative formats span live symposia, regional and local meetings, audio/video podcasts, multimedia webinars and roundtables, and other interactive formats, all grounded in real-world clinical challenges and enriched by expert perspectives. "Joining The Lockwood Group provides us the opportunity to further advance our mission of improving cancer care through education," said Dr Love. "Their strategic insight and global capabilities will help us further elevate and expand the ways we connect with and support the diverse needs of oncology clinicians." The partnership between The Lockwood Group and Research To Practice unites 2 organizations deeply committed to the people behind the science - clinicians, researchers, and patients. Together, they will continue to expand access to trusted, evidence-based education that drives better decisions and better care across the oncology community. About The Lockwood Group The Lockwood Group is a global pharma services organization with over 700 employees, that partners with pharmaceutical and biotechnology companies to translate complex science into compelling strategies that drive clinical and commercial success. Learn more at www.thelockwoodgrp.com. About Research To Practice RTP is a medical education company based in Miami, FL, specializing in physician and allied health professional education, focused exclusively on oncology and hematology. Founded and led by medical oncologist Neil Love, MD, RTP has provided meaningful, relevant, and unbiased educational perspectives for more than 40 years to meet the needs of oncology clinicians and positively impact the care of patients with cancer. Learn more at www.researchtopractice.com CONTACTS: The Lockwood Group [email protected] SOURCE The Lockwood Group